These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 26455404)

  • 21. Role of p38 and inducible nitric oxide synthase in the in vivo dopaminergic cells' degeneration induced by inflammatory processes after lipopolysaccharide injection.
    Ruano D; Revilla E; Gavilán MP; Vizuete ML; Pintado C; Vitorica J; Castaño A
    Neuroscience; 2006 Jul; 140(4):1157-68. PubMed ID: 16713109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease.
    McCoy MK; Martinez TN; Ruhn KA; Szymkowski DE; Smith CG; Botterman BR; Tansey KE; Tansey MG
    J Neurosci; 2006 Sep; 26(37):9365-75. PubMed ID: 16971520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential of the cannabinoid CB(2) receptor as a pharmacological target against inflammation in Parkinson's disease.
    Gómez-Gálvez Y; Palomo-Garo C; Fernández-Ruiz J; García C
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():200-8. PubMed ID: 25863279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic infusion of naloxone reduces degeneration of rat substantia nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide.
    Liu B; Jiang JW; Wilson BC; Du L; Yang SN; Wang JY; Wu GC; Cao XD; Hong JS
    J Pharmacol Exp Ther; 2000 Oct; 295(1):125-32. PubMed ID: 10991969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroprotective effect of nicotine on dopaminergic neurons by anti-inflammatory action.
    Park HJ; Lee PH; Ahn YW; Choi YJ; Lee G; Lee DY; Chung ES; Jin BK
    Eur J Neurosci; 2007 Jul; 26(1):79-89. PubMed ID: 17581257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vanillin Protects Dopaminergic Neurons against Inflammation-Mediated Cell Death by Inhibiting ERK1/2, P38 and the NF-κB Signaling Pathway.
    Yan X; Liu DF; Zhang XY; Liu D; Xu SY; Chen GX; Huang BX; Ren WZ; Wang W; Fu SP; Liu JX
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Possible mechanisms of the protective effect of ginsenoside Rg1 on apoptosis in substantia nigra neurons].
    Chen Y; Chen XC
    Yao Xue Xue Bao; 2002 Apr; 37(4):249-52. PubMed ID: 12579817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Luteolin protects dopaminergic neurons from inflammation-induced injury through inhibition of microglial activation.
    Chen HQ; Jin ZY; Wang XJ; Xu XM; Deng L; Zhao JW
    Neurosci Lett; 2008 Dec; 448(2):175-9. PubMed ID: 18952146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of M1/M2 polarization by capsaicin contributes to the survival of dopaminergic neurons in the lipopolysaccharide-lesioned substantia nigra in vivo.
    Bok E; Chung YC; Kim KS; Baik HH; Shin WH; Jin BK
    Exp Mol Med; 2018 Jul; 50(7):1-14. PubMed ID: 29968707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombin-induced microglial activation produces degeneration of nigral dopaminergic neurons in vivo.
    Choi SH; Joe EH; Kim SU; Jin BK
    J Neurosci; 2003 Jul; 23(13):5877-86. PubMed ID: 12843292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
    Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prothrombin kringle-2 induces death of mesencephalic dopaminergic neurons in vivo and in vitro via microglial activation.
    Kim SR; Chung ES; Bok E; Baik HH; Chung YC; Won SY; Joe E; Kim TH; Kim SS; Jin MY; Choi SH; Jin BK
    J Neurosci Res; 2010 May; 88(7):1537-48. PubMed ID: 20025058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ginsenoside Rg1 protection against β-amyloid peptide-induced neuronal apoptosis via estrogen receptor α and glucocorticoid receptor-dependent anti-protein nitration pathway.
    Wu J; Pan Z; Wang Z; Zhu W; Shen Y; Cui R; Lin J; Yu H; Wang Q; Qian J; Yu Y; Zhu D; Lou Y
    Neuropharmacology; 2012 Sep; 63(3):349-61. PubMed ID: 22534050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effect of ginsenoside Rg1 against MPTP-induced apoptosis in mouse substantia nigra neurons.
    Chen XC; Chen Y; Zhu YG; Fang F; Chen LM
    Acta Pharmacol Sin; 2002 Sep; 23(9):829-34. PubMed ID: 12230953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catalpol protects dopaminergic neurons from LPS-induced neurotoxicity in mesencephalic neuron-glia cultures.
    Tian YY; An LJ; Jiang L; Duan YL; Chen J; Jiang B
    Life Sci; 2006 Dec; 80(3):193-9. PubMed ID: 17049947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Curcumin protects dopaminergic neurons against inflammation-mediated damage and improves motor dysfunction induced by single intranigral lipopolysaccharide injection.
    Sharma N; Sharma S; Nehru B
    Inflammopharmacology; 2017 Jun; 25(3):351-368. PubMed ID: 28409389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-inflammatory effects of ginsenoside Rg1 and its metabolites ginsenoside Rh1 and 20(S)-protopanaxatriol in mice with TNBS-induced colitis.
    Lee SY; Jeong JJ; Eun SH; Kim DH
    Eur J Pharmacol; 2015 Sep; 762():333-43. PubMed ID: 26054809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ginsenoside Rg1 exerts synergistic anti-inflammatory effects with low doses of glucocorticoids in vitro.
    Song Y; Zhao F; Zhang L; Du Y; Wang T; Fu F
    Fitoterapia; 2013 Dec; 91():173-179. PubMed ID: 24035860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Galectin-1 attenuates neurodegeneration in Parkinson's disease model by modulating microglial MAPK/IκB/NFκB axis through its carbohydrate-recognition domain.
    Li Y; Chen N; Wu C; Lu Y; Gao G; Duan C; Yang H; Lu L
    Brain Behav Immun; 2020 Jan; 83():214-225. PubMed ID: 31669519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ginsenoside Rg1 reduces MPTP-induced substantia nigra neuron loss by suppressing oxidative stress.
    Chen XC; Zhou YC; Chen Y; Zhu YG; Fang F; Chen LM
    Acta Pharmacol Sin; 2005 Jan; 26(1):56-62. PubMed ID: 15659115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.